Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
SpyGlass Pharma, Inc.
organization3 mentionslast seen Nov 12, 2026
Late-stage biopharmaceutical company developing a drug-delivery intraocular lens system.
Relationships 11
- SpyGlass Pharma, Inc.employsJean-Frédéric Viret99% confidence3 sources
- SpyGlass Pharma, Inc.employsPatrick Mooney99% confidence3 sources
- SpyGlass Pharma, Inc.developsBIM-IOL System99% confidence3 sources
- SpyGlass Pharma, Inc.acquiresAdvanced Vision Science, Inc.99% confidence2 sources
- SpyGlass Pharma, Inc.developsnon-bioerodible drug delivery99% confidence2 sources
- Advanced Vision Science, Inc.suppliesSpyGlass Pharma, Inc.96% confidence1 source
- SpyGlass Pharma, Inc.developsBimatoprost-Drug Ring System96% confidence1 source
- SpyGlass Pharma, Inc.employsPaul Yoo96% confidence1 source
- SpyGlass Pharma, Inc.depends onnon-bioerodible drug delivery93% confidence1 source
- SpyGlass Pharma, Inc.authoredMalik Y. Kahook92% confidence1 source
- SpyGlass Pharma, Inc.authoredGlenn Sussman92% confidence1 source
Relationship
SpyGlass Pharma, Inc.developsnon-bioerodible drug delivery
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 19, 2026SpyGlass Pharma, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology
- filingSEC EDGAROct 1, 2026SpyGlass Pharma, Inc. 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology